REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $16,901 | +74.2% | 94 | +54.1% | 0.00% | – |
| Q3 2023 | $9,700 | +22.4% | 61 | +8.9% | 0.00% | – |
| Q2 2023 | $7,922 | -17.5% | 56 | -1.8% | 0.00% | – |
| Q1 2023 | $9,597 | +137000.0% | 57 | +35.7% | 0.00% | – |
| Q4 2022 | $7 | -99.9% | 42 | -17.6% | 0.00% | – |
| Q3 2022 | $10,000 | +400.0% | 51 | +325.0% | 0.00% | – |
| Q2 2022 | $2,000 | -66.7% | 12 | -61.3% | 0.00% | – |
| Q1 2022 | $6,000 | -14.3% | 31 | +24.0% | 0.00% | – |
| Q4 2021 | $7,000 | +16.7% | 25 | +13.6% | 0.00% | – |
| Q3 2021 | $6,000 | +50.0% | 22 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | 0.0% | 22 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | 0.0% | 22 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 22 | -18.5% | 0.00% | – |
| Q3 2020 | $4,000 | – | 27 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |